Evogene Limited operates in the Commercial physical research sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Evogene Limited with three other
miscellaneous service companies in Middle East:
sales of 1.03 million Israel Shekels [US$281,949.56 ]
Redhill Biopharma Ltd
(11,658.18 Israel Shekels [US$3,197.49 ]
Clal Biotechnology Industries Limited
(31.77 million Israel Shekels [US$8.71 million]
of which 94%
Evogene Limited reported sales of 43.25 million Israel Shekels (US$11.86 million)
December of 2015.
decrease of 16.9%
versus 2014, when the company's sales were 52.04 million Israel Shekels.
The sales level in 2015 was fairly close to the level five years ago: in 2010, Evogene Limited had sales
of 46.85 million Israel Shekels.